Efficacy of endoscopic gastroduodenal stenting for gastric outlet obstruction due to unresectable advanced gastric cancer: A prospective multicenter study

Journal of Surgical Oncology

Volumn 109, Issue 3, 2014, Pages 208-212

  Endo, Shunji ^a   Takiguchi, Shuji ^b   Miyazaki, Yasuhiro ^b   Nishikawa, Kazuhiro ^c   Imamura, Hiroshi ^d   Takachi, Ko ^e   Kimura, Yutaka ^f   Takeno, Atsushi ^g   Tamura, Shigeyuki ^g   Mori, Masaki ^b   Doki, Yuichiro ^b  

^a Higashiosaka City General Hospital   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d Sakai City Medical Center   (Japan)

^e Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^f OSAKA POLICE HOSPITAL   (Japan)

^g KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

gastric outlet obstruction; stent; stomach neoplasms

Indexed keywords

ALBUMIN; CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; HEMOGLOBIN; TRASTUZUMAB;

ADULT; ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EXAMINATION; DIET RESTRICTION; DUODENUM STENT; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; FEMALE; FOLLOW UP; FOOD INTAKE; GASTRECTOMY; GASTROJEJUNOSTOMY; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INOPERABLE CANCER; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NUTRITIONAL VALUE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEUM METASTASIS; PERITONITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SELF EXPANDING STENT; STOMACH ADENOCARCINOMA; STOMACH OBSTRUCTION; SURVIVAL TIME; TUMOR INVASION; TUMOR PERFORATION; VERY ELDERLY;

GASTRIC OUTLET OBSTRUCTION; STENT; STOMACH NEOPLASMS;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EQUIPMENT DESIGN; FEMALE; GASTRIC OUTLET OBSTRUCTION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUTRITIONAL STATUS; PALLIATIVE CARE; PROSPECTIVE STUDIES; SERUM ALBUMIN; STENTS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84893637063     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23486     Document Type: Article

References (13)

1. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-123.
2. Takeno A, Takiguchi S, Fujita J, et al.: Clinical outcome and indications for palliative gastrojejunostomy in unresectable advanced gastric cancer: Multi-institutional retrospective analysis. Ann Surg Oncol 2013; 20: 3527-3533.
3. Jeurnink SM, Steyerberg EW, van Hooft JE, et al.: Dutch SUSTENT Study Group. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): A multicenter randomized trial. Gastrointest Endosc 2010; 71: 490-499.
4. Chandrasegaram MD, Eslick GD, Mansfield CO, et al.: Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction. Surg Endosc 2012; 26: 323-329.
5. Sobin LH, Gospodarowicz MK, Wittekind C:, TNM classification of malignant tumors, 7th edition. Oxford: Wiley -Blackwell; 2009; pp 73-77.
6. Oken MM, Creech RH, Tormey DC, et al.: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
7. Adler DG, Baron TH:, Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: Experience in 36 patients. Am J Gastroenterol 2002; 97: 72-78.
8. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-112.
9. Canena JM, Lagos AC, Marques IN, et al.: Oral intake throughout the patients' lives after palliative metallic stent placement for malignant gastroduodenal obstruction: A retrospective multicentre study. Eur J Gastroenterol Hepatol 2012; 24: 747-755.
10. Sasaki T, Isayama H, Nakai Y, et al.: Predictive factors of solid food intake in patients with malignant gastric outlet obstruction receiving self-expandable metallic stents for palliation. Dig Endosc 2012; 24: 226-230.
11. Sasaki T, Isayama H, Maetani I, et al.: Japanese multicenter estimation of WallFlex duodenal stent for unresectable malignant gastric outlet obstruction. Dig Endosc 2013; 25: 1-6.
12. No JH, Kim SW, Lim CH, et al.: Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: Endoscopic stenting versus surgery. Gastrointest Endosc 2013; 78: 55-62.
13. Koizumi W, Narahara H, Hara T, et al.: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial. Lancet Oncol 2008; 9: 215-221.